Company: SCLXW
Filing Date: 2025-01-17
Form Type: 424B3
Source: 0000950170-25-006774
Chunk: 107

Company: Scilex Holding Co
Filing Date: 2025-01-17
Form: 424B3
Chunk 107
---
 Cash Flow Data:                                          |     | Nine Months Ended September 30, 
 2024                            |         |   |     | 2023 |         |   |
|:---------------------------------------------------------|:----|:--------------------------------|--------:|:--|:----|:-----|--------:|:--|
| Net cash proceeds from (used for) operating activities   |     | $                               |  16,815 |   |     | $    | (15,317 | ) |
| Net cash used for investing activities                   |     |                                 |  (2,480 | ) |     |      |    (163 | ) |
| Net cash (used for) proceeds from financing activities   |     |                                 | (10,948 | ) |     |      |  15,276 |   |
| Net change in cash, cash equivalents and restricted cash |     | $                               |   3,387 |   |     | $    |    (204 | ) |

Cash Flows from Operating Activities

For the nine months ended September 30, 2024, net cash proceeds from operating activities were approximately $16.8 million, attributable to our net loss of $66.3 million, offset by other non-cash reconciling items of $28.3 million related to stock-based compensation, change in fair value of debt and liability instruments, allocated expense for warrant issuance cost, depreciation and amortization and non-cash operating lease cost, gain on derivative liabilities, and changes in operating assets and liabilities that provided $54.9 million of cash.

For the nine months ended September 30, 2023, net cash used for operating activities was approximately $15.3 million, attributable to our net loss of $92.9 million, partially offset by other non-cash reconciling items of $20.3 million related to loss on derivative liabilities, stock-based compensation, change in fair value of debt and liability instruments, depreciation and amortization and non-cash operating lease cost, and changes in operating assets and liabilities that provided $57.3 million of cash.

Cash Flows from Investing Activities

For the nine months ended September 30, 2024, net cash used for investing activities was approximately $2.5 million and is primarily related to the $2.0 million purchase of Denali shares and $0.5 million related to payments of deferred consideration for the Romeg intangible asset acquisition under that certain license agreement, dated as of June 14 2022